TITLE: HYPERTENSIVE CRISES: EMERGENCIES AND URGENCIES
AUTHOR: DONALD VIDT, MD -- Department of Nephrology
PUBLISHED: MARCH 5, 2003
    
Table 1:
Clinical Characteristics of the Hypertensive Emergency

Blood
Pressure

Funduscopic
Findings
Neurologic Status Cardiac Findings Renal
Symptoms
Gastrointestinal
Symptoms
Usually >220/140
mm Hg
Hemorrhages, exudates, papilledema Headache, confusion, somnolence, stupor, visual loss, seizures, focal neurologic deficits, coma Prominent apical pulsation, cardiac enlargement, congestive heart failure Azotemia, proteinuria, oliguria Nausea, vomiting

 

Table 2:
Triage Evaluation:

Emergency vs. Uncontrolled Hypertension
Blood Pressure
>220/140 mm Hg
 
>180/120 mm Hg
Symptoms SOB
Chest Pain
nocturia
dysarthia
weakness
altered consciousness
 

Headache
SOB
epistaxis
edema
often asypmtomatic

Examination encephalopathy
pulmonary edema
renal insufficiency
cerebrovascular accident
acute coronary syndrome
  may have TOD
clinical CVD present
stable, often no TOD/CVD
Therapy baseline laboratory tests
intravenous line
monitor BP
may initiate therapy in ED
  observe
initiate/resume medication(s)
increase dose of inadequate agent
Plan Immediate admission to monitored unit
parenteral agents
treat to initial goal BP
additional diagnostic studies if needed
  arrange follow-up <24 hours to several days if no prior evaluation, schedule appointment
  
Copyright 2003 The Cleveland Clinic Foundation

 

 

 

 

 

Table 3:
Management of Hypertensive Emergencies
Agent
Dose
Onset/Duration of Action (after discontinuation)
Precautions
Parenteral Vasodilators
Sodium nitroprusside 0.25-10 µg/kg/min as IV infusion Immediate/2-3 min after infusion Nausea, vomiting; with prolonged use may cause thiocyanate intoxication, methemoglobinemia, acidosis, cyanide poisoning; bags, bottles, and delivery sets must be light resistant
Nitroglycerin 5-100 µg as IV infusion* 2-5 min/5-10 min Headache, tachycardia, vomiting, flushing, methemoglobinemia; requires special delivery system due to drug binding to PVC tubing
Nicardipine 5-15 mg/hr IV infusion 1-5 min/15-30 min, but may exceed 12 hr after prolonged infusion Tachycardia, nausea, vomiting, headache, increased intracranial pressure; hypotension may be protracted after prolonged infusions
Diazoxide 50-150 mg as IV bolus, repeated or 15-30 mg/min by IV infusion 2-5 min/3-12 hr Hypotension, tachycardia, aggravation of angina pectoris, nausea and vomiting, hyperglycemia with repeated injections
Fenoldapam mesylate 0.1-0.3 µg/kg/min IV infusion <5 min/30 min Headache, tachycardia, flushing, local phlebitis, dizziness
Hydralazine 5-20 mg as IV bolus or 10-40 mg IM; repeat every 4-6 hr 10 min IV/>1hr (IV) 20-30 min IM/4-6 hr (IM) Tachycardia, headache, vomiting, aggravation of angina pectoris, sodium & water retention and increased intracranial pressure
Enalaprilat 0.625-1.25 mg every 6 hr IV Within 30 min/12-24 hr Renal failure in patients with bilateral renal artery stenosis, hypotension
Parenteral Adrenergic Inhibitors
Labetalol 20-40 mg as IV bolus every 10 min; up to 2 mg/min as IV infusion 5-10 min/2-6 hr Bronchoconstriction, heart block, orthostatic hypotension, bradycardia
Esmolol 500 µg/kg bolus injection IV or 50-100 µg/kg/min by infusion. May repeat bolus after 5 min or increase infusion rate to 300 µg/kg/min 1-5 min/15-30 min First-degree heart block, congestive heart failure, asthma
Phentolamine 5-10 mg as IV bolus 1-2 min/10-30 min Tachycardia, orthostatic hypotension
* Requires special delivery system
hr=hour(s); min=minute; IV=intravenous; IM=intramuscular; PVC=polyvinyl chloride

This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this web site.

Copyright 2003 The Cleveland Clinic Foundation